Dr. Friedman is Professor of Clinical Psychiatry at Weill Cornell Medical College and Director of the Psychopharmacology Clinic in the Department of Psychiatry. Dr. Friedman has interest and expertise in the psychopharmacology and neurobiology of mood disorders and, in particular, treatment-resistant depression. At Cornell, he is actively involved in teaching and training psychiatric residents and medical students. He also does research in depressive disorders, including studies of new medications for depression and a large collaborative study of the genetics and neurobiology of bipolar disorder.
Dr. Friedman writes for several medical journals, including the New England Journal of Medicine and the Journal of the American Medical Association, on psychiatric topics. He is also a regular contributor to the science section of the New York Times, where he writes columns on behavioral science.
